Tag: biosimilar vs generic

Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025

Biosimilar Approval: How the FDA Reviews Biologic Alternatives in 2025

Learn how the FDA's 2025 update to biosimilar approval rules is accelerating access to lower-cost biologic alternatives, why they're not the same as generics, and what this means for patients and providers.

RECENT POSTS

January 8, 2026
Effective Patent Life: Why Market Exclusivity for Drugs Is Shorter Than You Think

Effective patent life for drugs is often just 10-13 years, not 20, because development and approval eat up half the patent term. Learn how patents, exclusivities, and legal tactics delay generic competition.

October 23, 2025
Enzymes and Cancer Prevention: How Enzyme Deficiency Increases Risk

Discover how enzymes prevent cancer, what happens when they're lacking, and practical steps to boost protective enzyme activity for better health.

June 12, 2023
Goutweed: The Secret Weapon in Your Battle Against Inflammation and Joint Pain

In my latest blog post, I've discovered an incredible secret weapon in the fight against inflammation and joint pain: Goutweed! This powerful herb has been used for centuries in traditional medicine and is now gaining recognition in modern times. Goutweed contains potent anti-inflammatory properties which can help alleviate joint pain and improve overall health. I've been amazed by the results I've experienced after incorporating Goutweed into my daily routine. Check out my blog to learn more about this amazing plant and how it can help you in your battle against inflammation and joint pain!

October 1, 2025
Understanding Post-Stroke Depression: Causes, Signs & Treatment

Learn what post-stroke depression is, its causes, key symptoms, and effective treatment options, including meds, therapy, and rehab strategies.

November 7, 2025
Vaccine Generics: Why Global Production and Access Remain Unequal

Vaccine generics don't exist like drug generics-complex manufacturing, supply chains, and profit-driven systems keep low-income countries dependent on imports. Here's why global vaccine access remains unequal.